Close Menu

drug development

In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.

In a talk at the AAAS meeting in Chicago, Stanford University bioengineer Drew Endy said that the US needs a national initiative to support and encourage synthetic biology.

The patent, called “Fragment Complementation Assays for G Protein-Coupled Receptors and Their Signaling Pathways,” solidifies Odyssey’s position in complex-based assays, and adds depth to its IP coverage in these two areas, an Odyssey official told CBA News this week.

Scientists should “be very aware” of the “limitations” of bioluminescent reporters, and contemplate running control assays before interpreting data from high-throughput screens, NCGC researchers said.

Affy aims to target downstream genomic-analysis markets with the products gained through its acquisitions of Panomics and True Materials last year, roll out new genotyping assays on its GeneTitan array platform, and consolidate its manufacturing facilities.

Researchers from the National Institutes of Health's Chemical Genomics Center warn that the firefly luciferase enzyme may show enhanced activity with some compounds — potentially leading to false positive results.

Christian Johansson, Gov. Martin O'Malley, Ambrose Schwallie, Jonathan Fleming, Doug Cole, Jean George, Christopher Schaber, Paul Alivisatos, Steve Chu, President Barack Obama, Jay Keasling, Greg Kessler, Jeffrey New

scientists may be years away from developing genomics-based medical treatments and therapies, but the hype surrounding the news that rese

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.